Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. [electronic resource] by
- Poljakova, Jitka
- Hrebackova, Jana
- Dvorakova, Marketa
- Moserova, Michaela
- Eckschlager, Tomas
- Hrabeta, Jan
- Göttlicherova, Marketa
- Kopejtkova, Barbora
- Frei, Eva
- Kizek, Rene
- Stiborova, Marie
Producer: 20120412
In:
Neuro endocrinology letters vol. 32 Suppl 1
Availability: No items available.
|
|
|
19.
|
The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide. [electronic resource] by
- Stiborová, Marie
- Sejbal, Jan
- Borek-Dohalská, Lucie
- Aimová, Dagmar
- Poljaková, Jitka
- Forsterová, Kristina
- Rupertová, Martina
- Wiesner, Jirí
- Hudecek, Jirí
- Wiessler, Manfred
- Frei, Eva
Producer: 20050224
In:
Cancer research vol. 64
Availability: No items available.
|
|
|
20.
|
Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells. [electronic resource] by
- Hrabeta, Jan
- Groh, Tomas
- Khalil, Mohamed Ashraf
- Poljakova, Jitka
- Adam, Vojtech
- Kizek, Rene
- Uhlik, Jiri
- Doktorova, Helena
- Cerna, Tereza
- Frei, Eva
- Stiborova, Marie
- Eckschlager, Tomas
Producer: 20160517
In:
International journal of oncology vol. 47
Availability: No items available.
|